UK markets open in 6 hours 4 minutes

Amgen Inc. (4332.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1,761.000+1,761.000 (-4.81%)
At close: 09:20AM HKT
Full screen
Previous close1,850.000
Open1,761.000
Bid1,761.000 x N/A
Ask0.000 x N/A
Day's range1,761.000 - 1,761.000
52-week range1,761.000 - 1,850.000
Volume50
Avg. volume0
Market cap1.089T
Beta (5Y monthly)0.58
PE ratio (TTM)16.03
EPS (TTM)109.890
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yield66.66 (3.60%)
Ex-dividend date16 Nov 2023
1y target est248.18
  • PR Newswire

    FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

    Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy. IMDELLTRA has received accelerated approval based on the encouraging response rate and duration of response (DoR) observed in clinical studies. Continued approval for this indication may be contingent upon verificatio

  • PR Newswire

    AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024

    Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS) International Conference on May 19 and 20, 2024. The presentation will also include an overview of additional programs from Amgen's innovative inflammation portfolio. Jay Bradner, executive vice president of Research and Development and chief

  • Simply Wall St.

    We Wouldn't Be Too Quick To Buy Amgen Inc. (NASDAQ:AMGN) Before It Goes Ex-Dividend

    Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...